Evidence map›Paper›PMID 42417221›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Lactoferrin-Templated Silver Peroxide Nanoparticles Reinforced Core-Shell Microneedle for Diabetic Infected Wound Sequential Therapy.

Jianying Hao, Xiang Ji, Xiuqiang Li, Qingyu Yu, Kaiyue Yang, Ding Lin, Zihan Chai, Linhua Zhang, Hong Zhang, Fanglian Yao and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jianying HaoSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Xiang JiSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Xiuqiang LiSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Qingyu YuTianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Kaiyue YangTianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Ding LinSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Zihan ChaiTianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Linhua ZhangTianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Hong ZhangSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.ORCID 0000-0002-6633-9264
Fanglian YaoSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Dunwan ZhuTianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Junjie LiSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.ORCID 0000-0003-2152-6952

Funding

National Natural Science Foundation of China 32401129Natural Science Foundation of Tianjin Municipality 24JCZDJC00270
6 · The paper itself

Abstract

Diabetic wounds, prone to infection and delayed healing, represent a major clinical challenge. Traditional nanosilver-based antibacterial agents remain challenging, including complex preparation, tendency to agglomerate, and poor biocompatibility. Herein, we synthesized lactoferrin-silver oxide nanoparticles (LF-Ag

Indexed as

LactoferrinMetal NanoparticlesSilver CompoundsWound InfectionAnimalsAnti-Bacterial AgentsDiabetes Mellitus, ExperimentalMicroneedle Drug DeliveryPercutaneous Collagen InductionReactive Oxygen SpeciesWound HealingAnti-Bacterial AgentsLactoferrinReactive Oxygen SpeciesSilver Compoundsantibacterial effectcore–shell microneedlediabetic wound healingLF‐Ag2O2 nanoparticlessequential therapy

Identifiers

PMID42417221
PMCPMC13533222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.